Pauck, D., Sarikaya-Seiwert, S., Marquardt, V., Picard, D., Bartl, J., Blümel, L., . . . Remke, M. (2018). EPEN-34. HIGH-THROUGHPUT DRUG SCREENING OF PRIMARY CULTURES REVEALS IRREVERSIBLE ERBB2 INHIBITION AS NOVEL THERAPEUTIC VULNERABILITY OF EPENDYMOMAS. Neuro Oncol.
Style de citation ChicagoPauck, David, et al. "EPEN-34. HIGH-THROUGHPUT DRUG SCREENING OF PRIMARY CULTURES REVEALS IRREVERSIBLE ERBB2 INHIBITION AS NOVEL THERAPEUTIC VULNERABILITY OF EPENDYMOMAS." Neuro Oncol 2018.
Style de citation MLAPauck, David, et al. "EPEN-34. HIGH-THROUGHPUT DRUG SCREENING OF PRIMARY CULTURES REVEALS IRREVERSIBLE ERBB2 INHIBITION AS NOVEL THERAPEUTIC VULNERABILITY OF EPENDYMOMAS." Neuro Oncol 2018.
Attention : ces citations peuvent ne pas être correctes à 100%.